Piramal Pharma Ltd

NSE: PPLPHARMA · BSE: 543635 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹206.59
Market cap: ₹27,504 Cr
Revenue (annual): ₹8,869 Cr
Net profit (annual): ₹-325.9 Cr
P/E (TTM): -87.7×Sector 49.7×
Promoter holding: 34.80%-0.06% QoQ
FII holding: 12.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 7 Other Announcement 6 Financial Results 3 Share Pledge 2 Results Update 2 Regulatory Approval 2 Merger & Restructuring 2 Employee Stock Options 2 Annual General Meeting 2 Management Change 1 Earnings Call 1 Board Meeting Date 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

18 Aug 2026 11:34 IST BSE

Merger & Restructuring

Piramal Pharma Merger & Restructuring Worth ₹76 Cr

Piramal Pharma acquired an additional 40.67% stake in Yapan Bio for ₹76 Crore. This transaction increases its total holding to 74%, making Yapan Bio a subsidiary.

Value: ₹76.00 Cr

Read the filing ↗

10 Aug 2026 18:02 IST BSE

Merger & Restructuring

Piramal Pharma Merger & Restructuring

Piramal Pharma exercised a call option to acquire an additional 41% stake in Yapan Bio, becoming its majority shareholder with a 74% stake.

Read the filing ↗